139 related articles for article (PubMed ID: 7983813)
1. [Current studies on the identification of susceptibility genes for IDDM in NOD mice].
Miyazaki J; Ishii M; Tashiro F
Nihon Rinsho; 1994 Oct; 52(10):2772-7. PubMed ID: 7983813
[TBL] [Abstract][Full Text] [Related]
2. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
Nishimoto H; Kikutani H; Yamamura K; Kishimoto T
Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721
[TBL] [Abstract][Full Text] [Related]
3. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.
Lund T; O'Reilly L; Hutchings P; Kanagawa O; Simpson E; Gravely R; Chandler P; Dyson J; Picard JK; Edwards A
Nature; 1990 Jun; 345(6277):727-9. PubMed ID: 2163026
[TBL] [Abstract][Full Text] [Related]
4. MHC-linked susceptibility to type 1 diabetes in the NOD mouse: further localization of Idd16 by subcongenic analysis.
Fujisawa T; Ikegami H; Noso S; Yamaji K; Nojima K; Babaya N; Itoi-Babaya M; Hiromine Y; Kobayashi M; Makino S; Ogihara T
Ann N Y Acad Sci; 2006 Oct; 1079():118-21. PubMed ID: 17130541
[TBL] [Abstract][Full Text] [Related]
5. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
6. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
[TBL] [Abstract][Full Text] [Related]
7. MHC-linked diabetogenic gene of the NOD mouse: molecular mapping of the 3' boundary of the diabetogenic region.
Ikegami H; Kawaguchi Y; Ueda H; Fukuda M; Takakawa K; Fujioka Y; Fujisawa T; Uchida K; Ogihara T
Biochem Biophys Res Commun; 1993 Apr; 192(2):677-82. PubMed ID: 8097912
[TBL] [Abstract][Full Text] [Related]
8. Subcongenic analysis of the Idd13 locus in NOD/Lt mice: evidence for several susceptibility genes including a possible diabetogenic role for beta 2-microglobulin.
Serreze DV; Bridgett M; Chapman HD; Chen E; Richard SD; Leiter EH
J Immunol; 1998 Feb; 160(3):1472-8. PubMed ID: 9570569
[TBL] [Abstract][Full Text] [Related]
9. Contribution of class III MHC to susceptibility to type 1 diabetes in the NOD mouse.
Yamaji K; Ikegami H; Fujisawa T; Noso S; Nojima K; Babaya N; Itoi-Babaya M; Kobayashi M; Hiromine Y; Makino S; Ogihara T
Ann N Y Acad Sci; 2006 Oct; 1079():114-7. PubMed ID: 17130540
[TBL] [Abstract][Full Text] [Related]
10. Congenic mapping of the MHC-linked susceptibility to type 1 diabetes in the NOD mouse: at least two genes contribute to the Idd16 effect.
Hiromine Y; Fujisawa T; Noso S; Babaya N; Kawabata Y; Ikegami H
Ann N Y Acad Sci; 2008 Dec; 1150():90-2. PubMed ID: 19120274
[TBL] [Abstract][Full Text] [Related]
11. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
Yoshida K; Kikutani H
Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
[TBL] [Abstract][Full Text] [Related]
12. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.
Reich EP; Sherwin RS; Kanagawa O; Janeway CA
Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922
[TBL] [Abstract][Full Text] [Related]
13. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q.
Hashimoto L; Habita C; Beressi JP; Delepine M; Besse C; Cambon-Thomsen A; Deschamps I; Rotter JI; Djoulah S; James MR
Nature; 1994 Sep; 371(6493):161-4. PubMed ID: 8072544
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice.
Hattori M; Yamato E; Itoh N; Senpuku H; Fujisawa T; Yoshino M; Fukuda M; Matsumoto E; Toyonaga T; Nakagawa I; Petruzzelli M; McMurray A; Weiner H; Sagai T; Moriwaki K; Shiroishi T; Maron R; Lund T
J Immunol; 1999 Aug; 163(4):1721-4. PubMed ID: 10438898
[TBL] [Abstract][Full Text] [Related]
15. Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans.
Serreze DV; Niens M; Kulik J; Dilorenzo TP
Methods Mol Biol; 2010; 602():119-34. PubMed ID: 20012396
[TBL] [Abstract][Full Text] [Related]
16. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
17. Genetic control of autoimmune diabetes in the NOD mouse.
Wicker LS; Todd JA; Peterson LB
Annu Rev Immunol; 1995; 13():179-200. PubMed ID: 7612220
[TBL] [Abstract][Full Text] [Related]
18. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
19. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy.
Brayer J; Lowry J; Cha S; Robinson CP; Yamachika S; Peck AB; Humphreys-Beher MG
J Rheumatol; 2000 Aug; 27(8):1896-904. PubMed ID: 10955330
[TBL] [Abstract][Full Text] [Related]
20. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
